Company / Operating Income
Sigyn Therapeutics, Inc. Operating Income History
FY2015-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$518.0K
FY2019
5-year range
-$2.3M / -$518.0K
FY2015-FY2019
Trend
+48.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$2M to -$517,958 over the past 4 years.
Based on SEC 10-K filings.
-$517,958 in FY2019.
Improved from -$2M to -$517,958 over the past 4 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, operating income increased 48.4% year-over-year.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | -$518.0K | +48.4% |
| FY2018 | -$1.0M | +55.4% |
| FY2015 | -$2.3M | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026